Controlled inhalation improves central and peripheral deposition in cystic fibrosis patients with moderate lung disease. (17th February 2022)

• Record Type: Journal Article
• Authors: Bourke, Crystal; Devadason, Sunalene; Ditcham, William; Depiazzi, Julie; Everard, Mark L
• Is Part Of: Journal of paediatrics and child health. Volume 58:Number 6(2022)
• Page Start: 1066
• Page End: 1068
• Publication Date: 2022-02-17
• Subjects: controlled inhalation -- cystic fibrosis -- moderate lung disease -- peripheral deposition; Children -- Health and hygiene -- Periodicals; Pediatrics -- Periodicals; 618.92
• DOI: 10.1111/jpc.15909
• Languages: English
• ISSNs: 1034-4810

Abstract

Abstract : Aim: With progressive impairment of lung function, deposition of inhaled drug in the lungs becomes progressively more central, limiting its effectiveness. This pilot study explored the possibility that long slow inhalations might improve delivery of aerosol to the lung periphery in cystic fibrosis patients with moderate lung disease. Methods: Five subjects aged 12–18 years (mean FEV1 72%; range 63–80%) inhaled a radiolabelled aerosol from a jet nebuliser on two occasions. Two inhalation techniques were compared: breathing tidally from a standard continuous output nebuliser and using long slow inhalations from the AKITA® JET system. Results: Long slow breaths resulted in much lower oropharyngeal deposition with higher lung doses. Importantly, the peripheral lung increased proportionately. The increased lung dose is attributable to more of the larger inhaled droplets passing into the lower airways. This would be expected to increase the central deposition unless significantly more of the smaller droplets were able to penetrate deeper into the lungs. The data support improved delivery of drug to the distal lung when compared with tidal breathing. Conclusion: These pilot data suggest that this approach may prove to be clinically relevant in improving the efficacy of inhaled medication in those with moderate‐severe lung disease.